These sex differences may be attributed to multiple factors such as disease severity across studies, the use of different NPS assessments, the genetic predisposition to AD including the interaction between sex and apoE4 in AD/MCI [99, 110], sex-related hormonal levels, or the use of pharmacological treatments [109]. This evidence concerns the gene APOE and Alzheimer disease.